Regulatory Story
Go to market news section View chart   Print
RNS
Bonitron DAC   -  IRSH   

Notice to Noteholders

Released 12:50 04-Dec-2018

RNS Number : 4086J
Bonitron DAC
04 December 2018
 

Announcement on each Trading Day

 

Purchase of the outstanding U.S.$350,000,000 8.75% Loan Participation Notes due 2022 issued by Bonitron Designated Activity Company

Date: 04.12.2018

 

Bonitron Designated Activity Company (the "Issuer") announces today that, Eurotorg LLC ("Eurotorg"), the Borrower under the U.S.$350,000,000.00 8.75 per cent. Loan Participation Notes due 2022 (the "Notes") issued by Bonitron, has purchased the Notes as set forth in the table below:

 

 

Notes:                                                                                5113

 

Date of purchase:                                                               04.12.2018

 

Principal amount of the Notes purchased:                         U.S.$ 5,113,000.00

 

 

Eurotorg intends to hold the purchased Notes in treasury.

The principal amount of the Notes outstanding after the above purchase is U.S.$ 340,361,000.00.

 

Since 26.11.2018, Eurotorg has purchased the U.S.$ 5,113,000.00 in aggregate principal amount of the Notes.

 

 

 

This announcement may contain inside information as defined in Article 7 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the "Market Abuse Regulation") and is disclosed in accordance with the Issuer's obligations under Article 17 of the Market Abuse Regulations.

 

 

 

For further information please contact:

 

EM (public relations advisor to Eurotorg)

 

Denis Denisov

denisov@em-comms.com

+7 985 410 3544

Peter Morley

morley@em-comms.com

+44 7927 186 645

 

 

Tom Blackwell

blackwell@em-comms.com

+7 919 102 9064

Maria Levitov

levitov@em-comms.com

+44 7553 092 429

 

Eurotorg LLC

 

Andrei Matsiavin

MatyavinA@eurotorg.by

+375 44 5006545

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEFSAFELFASELE
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Notice to Noteholders - RNS